An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B
Clinical trial NCT02554773 · COMPLETED
Trial details
- NCT number
- NCT02554773
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-18
- Primary completion
- 2023-03-21
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.